Professor Sheiner's research reaches over 10 million people
Published: 4 November 2024
The School of Infection & Immunity's Professor Lilach Sheiner recently shared her groundbreaking research with a Chinese television audience of over 10 million viewers in an interview for a segment on popular programme ‘Seeking Truth in News’.
The School of Infection & Immunity's Professor Lilach Sheiner recently shared her groundbreaking research with a Chinese television audience of over 10 million viewers.
Following the publication of the pioneering paper 'Engineering Toxoplasma gondii secretion systems for intracellular delivery of multiple large therapeutic proteins to neurons', Professor Sheiner was approached by Hunan TV.
A state satellite television station, Hunan TV is currently China's second-most-watched television channel, airing across the country, including Macau, Hong Kong, and Taiwan, and overseas in Japan, India, South Korea, New Zealand, Australia, and parts of Africa.
On Tuesday, 8 October 2024, Professor Sheiner was interviewed by host Wang Shanshan for a 10-minute segment on the popular science programme, ‘Seeking Truth in News’.
Exploring the work of top laboratories and international experts on the hot science issues of the day, the show ranks in the top three in China with a cumulative audience exceeding one billion.
Speaking to presenter Wang Shanshan, Professor Sheiner discussed Toxoplasma gondii and explained how she, Professor Oded Rechavi from Tel-Aviv University, and an international team of collaborators have pioneered a new way to deliver treatment to the brain using an engineered parasite.
News of this pioneering research was recently shared across Sii channels, and can be accessed at the link below.
Research uncovers pioneering method to deliver cognitive disorder treatment
With consent from Hunan TV, we have been able to acquire footage of the show, which is subtitled and overdubbed for a Chinese audience, and upload to our YouTube channel, which has been embedded, above.
First published: 4 November 2024